These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A case of flecainide-induced hyponatremia. Ahmed M; Sra J; Akhtar M; Mortada ME J Cardiovasc Electrophysiol; 2009 Oct; 20(10):1170-2. PubMed ID: 19298558 [TBL] [Abstract][Full Text] [Related]
4. [Outpatient treatment of recurrent atrial fibrillation with the "pill-in-the-pocket" approach: practical aspects]. Alboni P; Botto GL; Baldi N Ital Heart J Suppl; 2005 Jun; 6(6):335-40. PubMed ID: 16013424 [TBL] [Abstract][Full Text] [Related]
5. [Intravenous flecainide administration for conversion of paroxysmal atrial fibrillation in the emergency room]. Antonelli D; Feldman A; Freedberg NA; Darawsha A; Rosenfeld T Harefuah; 2006 May; 145(5):342-4, 398. PubMed ID: 16805213 [TBL] [Abstract][Full Text] [Related]
7. Flecainide as first-line treatment for supraventricular tachycardia in newborns. Ferlini M; Colli AM; Bonanomi C; Salvini L; Galli MA; Salice P; Ravaglia R; Centola M; Danzi GB J Cardiovasc Med (Hagerstown); 2009 May; 10(5):372-5. PubMed ID: 19300276 [TBL] [Abstract][Full Text] [Related]
8. Flecainide and propafenone induced ST-segment elevation in patients with atrial fibrillation: clue to specificity of Brugada-type electrocardiographic changes. Beldner S; Lin D; Marchlinski FE Am J Cardiol; 2004 Nov; 94(9):1184-5. PubMed ID: 15518618 [TBL] [Abstract][Full Text] [Related]
9. [Pharmacogenetic study of the response to flecainide and propafenone in patients with atrial fibrillation]. Martínez-Sellés M; Castillo I; Montenegro P; Martín ML; Almendral J; Sanjurjo M Rev Esp Cardiol; 2005 Jun; 58(6):745-8. PubMed ID: 15970126 [TBL] [Abstract][Full Text] [Related]
10. [Be careful in using flecainide by hemodialyzed patients]. Montagnac R; Schoen E; Aliouche CP; Schillinger F Nephrol Ther; 2006 Dec; 2(7):442-5. PubMed ID: 17185235 [TBL] [Abstract][Full Text] [Related]
11. [Severe flecainide acetate poisoning. Apropos of a case]. Maury P; Vuille C; Metzger J; Veragut B; Schoenenberger I; Elamly A; Chevrolet JC Arch Mal Coeur Vaiss; 1999 Feb; 92(2):273-7. PubMed ID: 10078349 [TBL] [Abstract][Full Text] [Related]
12. [Life-threatening ventricular tachycardia during flecainide treatment for symptomatic atrial fibrillation in a patient with a structural cardiac disorder]. Rienstra M; Wiesfeld AC; van Veldhuisen DJ; van Gelder IC Ned Tijdschr Geneeskd; 2006 May; 150(18):1027-31. PubMed ID: 16715868 [TBL] [Abstract][Full Text] [Related]
13. Does a Brugada pattern ECG precipitated by excessive-dose flecainide provide a diagnosis of a Brugada syndrome patient and/or contraindicate its use? A case study. Reiffel JA Circ Arrhythm Electrophysiol; 2011 Aug; 4(4):e47-51. PubMed ID: 21846883 [No Abstract] [Full Text] [Related]
14. Paranoid psychosis due to flecainide toxicity in malignant neuropathic pain. Bennett MI Pain; 1997 Mar; 70(1):93-4. PubMed ID: 9106813 [TBL] [Abstract][Full Text] [Related]
17. Randomized comparison of flecainide and cibenzoline in the conversion of atrial fibrillation. Kühlkamp V; Schmid F; Risler T; Seipel L Int J Cardiol; 1991 Apr; 31(1):65-9. PubMed ID: 1906432 [TBL] [Abstract][Full Text] [Related]
18. [Drug-induced asterixis amplified by relative hypoglycemia]. Poersch M; Hufnagel A; Smolenski C Nervenarzt; 1996 Apr; 67(4):323-6. PubMed ID: 8684512 [TBL] [Abstract][Full Text] [Related]
19. Assessment of serum flecainide trough levels in patients with tachyarrhythmia. Homma M; Kuga K; Doki K; Katori K; Yamaguchi I; Sugibayashi K; Kohda Y J Pharm Pharmacol; 2005 Jan; 57(1):47-51. PubMed ID: 15638992 [TBL] [Abstract][Full Text] [Related]
20. Neonatal flecainide toxicity following supraventricular tachycardia treatment. Hall CM; Ward Platt MP Ann Pharmacother; 2003 Sep; 37(9):1343-4. PubMed ID: 12921523 [No Abstract] [Full Text] [Related] [Next] [New Search]